1. DSpace at Riga Stradiņš University
  2. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
  3. Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure
Please use this identifier to cite or link to this item: 10.2478/prolas-2021-0052
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHartmane, Ilona-
dc.contributor.authorIvdra, Iveta-
dc.contributor.authorMikažāns, Ingmārs-
dc.contributor.authorBondare-Ansberga, Vanda-
dc.date.accessioned2021-11-23T10:20:01Z-
dc.date.available2021-11-23T10:20:01Z-
dc.date.issued2021-10-01-
dc.identifier.citationHartmane , I , Ivdra , I , Mikažāns , I & Bondare-Ansberga , V 2021 , ' Correlation of Immunological and Clinical Changes in Psoriasis Patients Treated with Tumour Necrosis Factor-Alpha (TNF-α) Blocking Biologic Drugs : one-year dynamic observation ' , Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. , vol. 75 , no. 5 , pp. 357-363 . https://doi.org/10.2478/prolas-2021-0052-
dc.identifier.issn2255-890X-
dc.identifier.otherunpaywall: 10.2478/prolas-2021-0052-
dc.identifier.otherMendeley: 0af89e08-3ce3-352f-9c0e-c3a0732bcc51-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6864-
dc.description.abstractPsoriasis is one of the most common autoimmune dermatoses with a chronic relapsing course. Biologic therapy should be initiated for patients with moderate to severe psoriasis when conventional systemic therapy and phototherapy are ineffective, or their use is limited due to comorbidities. In Latvia, adalimumab is the first choice of biologic drugs for treatment of psoriasis. The correlation between changes in cellular and humoral immunological parameters and clinical signs based on immunological data from psoriasis patients are evaluated in the publication.en
dc.format.extent7-
dc.format.extent1111027-
dc.language.isoeng-
dc.relation.ispartofProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectTNF-a inhibitors-
dc.subjectadalimumab-
dc.subjectparameters of cellular and humoral immunity-
dc.subjectT cells-
dc.subject3.2 Clinical medicine-
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database-
dc.titleCorrelation of Immunological and Clinical Changes in Psoriasis Patients Treated with Tumour Necrosis Factor-Alpha (TNF-α) Blocking Biologic Drugs : one-year dynamic observationen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.2478/prolas-2021-0052-
dc.contributor.institutionDepartment of Dermatology and Venereology-
dc.identifier.urlhttps://www.mendeley.com/catalogue/0af89e08-3ce3-352f-9c0e-c3a0732bcc51/-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
Correlation_of_immunological_and_clinical_changes.pdf1.08 MBAdobe PDFView/Openopen_acces_unlocked
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.